AngioDynamics Reports Fiscal 2017 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
AngioDynamics (ANGO) Tops Q2 EPS by 21c; Guides Roughly In-Line
January 6, 2017 6:06 AM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.37, $0.21 better than the analyst estimate of $0.16. Revenue for the quarter came in at $89 million versus the consensus estimate of $91.09 million.
GUIDANCE:
AngioDynamics sees FY2017 EPS of $0.65-$0.67, versus the consensus of $0.66. AngioDynamics sees... More
